JA Beckman, MA Creager, P Libby - Jama, 2002 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context Complications of ... Cited by 966 - Related articles - BL Direct - All 5 versions
- ►pharmyaring.com [PDF] SE Inzucchi - Jama, 2002 - Am Med Assoc Context Care of patients with type 2 diabetes has been revolutionized throughout
the past several years—first, by the realization of the importance of tight
glycemic control in forestalling complications, and second, by the ... Cited by 601 - Related articles - BL Direct - All 18 versions
RW Nesto, D Bell, RO Bonow, V Fonseca, SM … - Circulation, 2003 - Am Heart Assoc These beneficial effects of TZDs on glycemia and cardiovascular risk factors
have made them attractive agents in patients with type 2 diabetes who are at
high risk for CVD. There is a growing recognition, however, that edema can ... Cited by 569 - Related articles - BL Direct - All 17 versions
N Unwin, J Shaw, P Zimmet, KG Alberti - Diabetic medicine: a journal of the British Diabetic …, 2002 - ncbi.nlm.nih.gov A workshop was convened by the International Diabetes Federation to review the
latest information relating to the risks associated with impaired glucose
tolerance (IGT) and impaired fasting glycaemia (IFG) for future diabetes ... Cited by 403 - Related articles - All 3 versions
A Raji, EW Seely, SA Bekins, GH Williams, … - Diabetes care, 2003 - Am Diabetes Assoc RESULTS—There was no change in fasting plasma glucose (83 ± 2 vs. 82 ± 2
mg/dl, P = 0.60), but fasting insulin decreased (16.1 ± 1.4 vs. 12.5 ± 0.9
μU/ml, P < 0.01). Total glucose disposal during the clamp increased (5.0 ... Cited by 233 - Related articles - BL Direct - All 8 versions
JR Sowers - The American journal of medicine, 2003 - Elsevier The prevalence of overweight and obesity continues to increase rapidly in the
United States, with more than half of all adults currently overweight or obese.
In general, people become obese because of a combination of inherited genes ... Cited by 207 - Related articles - All 5 versions
AE Caballero - Obesity, 2003 - nature.com Obesity, insulin resistance, and endothelial dysfunction closely coexist
throughout the natural history of type 2 diabetes. They all can be identified
not only in people with type 2 diabetes, but also in various groups at risk ... Cited by 180 - Related articles - BL Direct - All 7 versions
- ►pnas.org H Zhang, A Zhang, DE Kohan, RD Nelson, FJ … - Proceedings of the National Academy of Sciences, 2005 - National Acad Sciences The peroxisome proliferator-activated receptor subtype γ (PPARγ) ligands,
namely the synthetic insulin-sensitizing thiazolidinedione (TZD) compounds, have
demonstrated great potential in the treatment of type II diabetes. However, ... Cited by 160 - Related articles - All 7 versions
BJ Goldstein - The American journal of cardiology, 2002 - Elsevier Insulin resistance is a major contributor to the pathogenesis of type 2 diabetes
and plays a key role in associated metabolic abnormalities, such as dyslipidemia
and hypertension. Obesity, especially visceral adiposity, is negatively ... Cited by 154 - Related articles - All 11 versions
